⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 1990Journal of Antimicrobial Chemotherapy

The in-vitro susceptibility of Alcatigenes deni-trificans subsp.xylosoxidans to40 anti-microbial agents

Kenneth V. I. Rolston Mark Messer

View at Publisher

Ask AI

Bookmark

Share

Abstract

KENNETH.V.I ROLSTON, MARK MESSER; The in-vitro susceptibility of Alcatigenes deni-trificans subsp.xylosoxidans to40 anti-microbial agents, Journal of Antimicrob

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rolston et al. (1990) studied this question.

synapsesocial.com/papers/6aa94883003e5934aecdc8e5 https://doi.org/10.1093/jac/26.6.857

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1No clinically relevant QTc prolongation with ceftibuten or ledaborbactam etzadroxil: concentration-QTc analyses from two phase I studiesJournal of Antimicrobial Chemotherapy · 2026
2Phylogenetic diversification of the PoxtA ribosomal protection determinantJournal of Antimicrobial Chemotherapy · 2026
3Beyond susceptibility: pharmacokinetic and pharmacodynamic constraints of existing oral antibiotics in extensively drug-resistant typhoid feverJournal of Antimicrobial Chemotherapy · 2026
4Tigecycline-resistant Staphylococcus in waiting pens of a pig slaughterhouse: genomic insights into a food safety alertJournal of Antimicrobial Chemotherapy · 2026
5Assessment of Enterococcus faecalis biofilm response to amoxicillin and ciprofloxacin using a dynamic in vitro pharmacokinetic–pharmacodynamic model of catheter-associated urinary tract infectionJournal of Antimicrobial Chemotherapy · 2026

The underappreciated role of rifampin in shaping the epidemiology of RT027-like Clostridioides difficile lineagesJournal of Antimicrobial Chemotherapy · 2026
Systematic screening identified broad-spectrum inhibitors of human-pathogenic Encephalitozoon species and revealed no in vitro activity of nitazoxanideJournal of Antimicrobial Chemotherapy · 2026
Weight-based polymyxin B dosing for mortality and nephrotoxicity: an exploratory dose–response studyJournal of Antimicrobial Chemotherapy · 2026
Targeting autolysin ATL of Streptococcus suis : structural insights and inhibition by lanreotide acetateJournal of Antimicrobial Chemotherapy · 2026
Pre-treatment HIV-1 drug resistance spectrum and molecular transmission network characteristics in Zhejiang Province, 2023: implications for targeted control of drug-resistant HIV transmissionJournal of Antimicrobial Chemotherapy · 2026

More from Journal of Antimicrobial Chemotherapy

More from The University of Texas MD Anderson Cancer Center